The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults Data from: Glucacop, Macicop, and CARGO study

被引:8
作者
Atila, Cihan [1 ,2 ]
Monnerat, Sophie [1 ,2 ]
Urwyler, Sandrine Andrea [1 ,2 ]
Refardt, Julie [1 ,2 ]
Winzeler, Bettina [1 ,2 ]
Christ-Crain, Mirjam [1 ,2 ]
机构
[1] Univ Hosp Basel, Dept Endocrinol Diabetol & Metab, Petersgraben 4, CH-4031 Basel, Switzerland
[2] Univ Basel, Dept Clin Res, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Copeptin; Glucagon; Macimorelin; Arginine; Pituitary stimulation test; ADRENOCORTICOTROPIN SECRETION; GH DEFICIENCY; NITRIC-OXIDE; HORMONE; VASOPRESSIN; DIAGNOSIS; CHILDHOOD; PRECURSOR; PATHWAYS; ANTERIOR;
D O I
10.1007/s11102-022-01240-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide novel tests to assess the posterior pituitary. The exact underlying mechanism behind their stimulatory effect remains elusive. Methods This analysis combined data from three diagnostic studies conducted at the University Hospital Basel, Switzerland. In total, 80 healthy adults underwent the glucagon (n = 22), arginine (n = 30), or macimorelin (n = 28) stimulation tests. The primary objective was to investigate glucose course upon glucagon, arginine, and macimorelin stimulation tests and its effect on plasma copeptin release. Results Upon glucagon stimulation, the median [IQR] glucose level at baseline was 5.0 [4.6, 5.2] mmol/l, peaked at 8.1 [7.2, 9.4] mmol/l after 30 min and decreased to a minimum of 3.8 [3.5, 4.5] mmol/l after 120 min. The median copeptin increase upon glucagon stimulation was 7.7 [2.6, 28.0] pmol/l. Upon arginine, the glucose level at baseline was 4.9 [4.8, 5.5] mmol/l, peaked at 6.0 [5.2, 6.4] mmol/l after 30 min and decreased to a minimum of 4.3 [3.8, 4.8] mmol/l after 60 min. The median copeptin increase upon arginine stimulation was 4.5 [2.9, 7.5] pmol/l. Upon macimorelin, glucose levels showed no notable dynamics over the 120 min, and no major change in copeptin was observed. In the pooled dataset, a decrease in glucose levels was significantly correlated with copeptin increase (rho = 0.53, p < 0.01). Conclusion A similar course in plasma glucose was observed in the copeptin-stimulating test, i.e., after glucagon and arginine, while macimorelin had no effect on glucose and copeptin levels. We hypothesize that a drop in glucose levels observed upon glucagon and arginine might stimulate copeptin.
引用
收藏
页码:636 / 644
页数:9
相关论文
共 25 条
[1]   VASOPRESSINERGIC CONTROL OF PITUITARY ADRENOCORTICOTROPIN SECRETION COMES OF AGE [J].
ANTONI, FA .
FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) :76-122
[3]   Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study [J].
Atila, Cihan ;
Gaisl, Odile ;
Vogt, Deborah R. ;
Werlen, Laura ;
Szinnai, Gabor ;
Christ-Crain, Mirjam .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (01) :65-74
[4]   Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso-, and Hyperosmolar States [J].
Balanescu, Sandrina ;
Kopp, Peter ;
Gaskill, Mary Beth ;
Morgenthaler, Nils G. ;
Schindler, Christian ;
Rutishauser, Jonas .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :1046-1052
[5]   Vasopressin receptors in health and disease [J].
Bichet, DG .
KIDNEY INTERNATIONAL, 1996, 49 (06) :1706-1711
[6]   LOCALIZATION OF NITRIC-OXIDE SYNTHASE INDICATING A NEURAL ROLE FOR NITRIC-OXIDE [J].
BREDT, DS ;
HWANG, PM ;
SNYDER, SH .
NATURE, 1990, 347 (6295) :768-770
[7]  
CHENG K, 1989, ENDOCRINOLOGY, V124, P2791
[8]   Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH Deficiency [J].
Garcia, J. M. ;
Swerdloff, R. ;
Wang, C. ;
Kyle, M. ;
Kipnes, M. ;
Biller, B. M. K. ;
Cook, D. ;
Yuen, K. C. J. ;
Bonert, V. ;
Dobs, A. ;
Molitch, M. E. ;
Merriam, G. R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (06) :2422-2429
[9]   The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells [J].
Henquin, Jean-Claude .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 :S27-S31
[10]   LOCATION OF CHEMORECEPTOR CONTROLLING GROWTH-HORMONE SECRETION DURING HYPOGLYCEMIA IN PRIMATES [J].
HIMSWORTH, RL ;
CARMEL, PW ;
FRANTZ, AG .
ENDOCRINOLOGY, 1972, 91 (01) :217-+